Search
Now showing items 1-1 of 1
An update on trials of novel lipid-lowering drugs
(2018-03)
PURPOSE OF REVIEW: A number of novel trials have assessed the efficacy of new lipid-lowering therapies in cardiovascular disease (CVD).
RECENT FINDINGS: Proprotein convertase subtilisin kexin-9 inhibitors reduce low-density ...